Liu et al reported that DTC patients with the TERT promoter mutation had larger tumors compared to those without this mutation,[17] reinforcing its role in thyroid cancer progression and its potential as a predictor of clinical outcomes in thyroid cancer patients. Here, TERT is linked to thyroid gland carcinoma.